-
Impact of Pharmacist Managed Pulmonary Arterial Hypertension Program on TYVASO Adherence
Mar 10, 2025, 14:00 PM -
Frequently Asked Questions (FAQs): What Are the Risks and Mitigation Strategies in Using Gen-AI in HEOR?
Mar 10, 2025, 14:00 PM -
What Non-Profit Development of Pretomanid Can Teach About Paths to Innovation and Global Access to Treatments for Diseases of Poverty?
Mar 10, 2025, 14:00 PM -
Real-World Characteristics and Treatment Patterns With Nintedanib in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective US Claims Study
Mar 10, 2025, 14:00 PM -
Therapeutic Applications of Drug-Coated Balloons in Symptomatic Intracranial Arterial Stenosis: A Systematic Review and Quantitative Meta-Analysis
Mar 10, 2025, 14:00 PM -
From AI to Experts: Understanding Pre-Election Inflation Narratives on Social Media via Sentiment and Topic Analysis
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis and Value-Based Pricing of Digital Therapeutics for Pulmonary Rehabilitation in Patients With Chronic Respiratory Disease: A Multicenter Randomized Controlled Trial
Mar 10, 2025, 14:00 PM -
Prevalence of Mental Health Conditions Among Individuals With Sickle Cell Disease in Texas Medicaid
Mar 10, 2025, 14:00 PM -
Frequency and Severity of COVID-19 Acute Symptoms Among Symptomatic US Adults Testing Positive for SARS-CoV-2: Early 2024-2025 Respiratory Season Results of a Nationwide Study
Mar 10, 2025, 14:00 PM -
A Model-Based Cost-Effectiveness Analysis of Anamorelin and Olanzapine in NSCLC Cachexia Treatment in Japan
Mar 10, 2025, 14:00 PM -
The Economic Burden of Illness for Patients with Idiopathic Pulmonary Fibrosis Utilizing Treatment Cohorts: A US Retrospective Claims Study
Mar 10, 2025, 14:00 PM -
Comparison of Suicidal Ideation or Personal History of Self Harm Among Patients with Use of Rexulti and All Antipsychotics
Mar 10, 2025, 14:00 PM -
Assessment of Disease Progression and Healthcare Resource Utilization Associated with Duchenne Muscular Dystrophy: A Retrospective Observational Study Using the Optum Market Clarity Database
Mar 10, 2025, 14:00 PM -
Evaluating Generative AI in Replicating Health Economic Models: A Case Study on Ulcerative Colitis
Mar 10, 2025, 14:00 PM -
Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination in US Adults Aged 60 Years with Cardiopulmonary Disease
Mar 10, 2025, 14:00 PM -
Continuous Avoidance Cost in Biosimilar: A Budget Impact Analysis on the Basis of Clinical Trial Model and RWD in Brazil / LATAM / LMIC .
Mar 10, 2025, 14:00 PM -
A Critical Review of Existing Shared Decision-Making Measuring Approaches in Studies Using the Medical Expenditure Panel Survey (MEPS)
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pembrolizumab in 1L Recurrent/Metastatic Head and Neck Squamous Cell Cancer (R/M HNSCC) in Brazil
Mar 10, 2025, 14:00 PM -
National and State Population-Level Estimated Economic Impact of Ocrelizumab on Cumulative Disabilities Avoided and Work Productivity Under Different Access Scenarios in the United States
Mar 10, 2025, 14:00 PM -
Health and Economic Impact Analysis of Uncontrolled Hemophilia Patients in Colombia
Mar 10, 2025, 14:00 PM
